A Collaboration of the San Antonio Bioscience and Medical Research Community

A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.

Research Organizations

2859

Research Projects

Latest Projects

Brooke Army Medical Center

A Phase 3, Open Label, Randomized Study Of LOXO-305 Versus Investigator’s Choice Of Idelalisib Plus Rituximab Or Bendamustine Plus Rituximab In Btk Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Brooke Army Medical Center

Effective Surveillance Of Chagas Disease For Us Military Readiness Along South West Us Mexico Border Ports Of Entry

Brooke Army Medical Center

An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma

Brooke Army Medical Center

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study To Assess The Efficacy And Safety Of Etrasimod In Subjects With Moderately To Severely Active Ulcerative C

Brooke Army Medical Center

Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab To Other Biologic Agents In Patients With Ulcerative Colitis Or Crohn's Disease

Brooke Army Medical Center

A Collaboration of the San Antonio Bioscience and Medical Research Community

Latest Projects

A Phase 3, Open Label, Randomized Study Of LOXO-305 Versus Investigator’s Choice Of Idelalisib Plus Rituximab Or Bendamustine Plus Rituximab In Btk Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Effective Surveillance Of Chagas Disease For Us Military Readiness Along South West Us Mexico Border Ports Of Entry

An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study To Assess The Efficacy And Safety Of Etrasimod In Subjects With Moderately To Severely Active Ulcerative C

Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab To Other Biologic Agents In Patients With Ulcerative Colitis Or Crohn's Disease

The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Trending Research

Bioscience Research Panel

A Collaboration of the San Antonio Bioscience and Medical Research Community

Latest Projects

A Phase 3, Open Label, Randomized Study Of LOXO-305 Versus Investigator’s Choice Of Idelalisib Plus Rituximab Or Bendamustine Plus Rituximab In Btk Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Effective Surveillance Of Chagas Disease For Us Military Readiness Along South West Us Mexico Border Ports Of Entry

An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study To Assess The Efficacy And Safety Of Etrasimod In Subjects With Moderately To Severely Active Ulcerative C

Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab To Other Biologic Agents In Patients With Ulcerative Colitis Or Crohn's Disease

The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Trending Research